PubMed

Treatment of chronic hepatitis C in a state correctional facility.

Allen SA, Spaulding AC, Osei AM, Taylor LE, Cabral AM, Rich JD.

Ann Intern Med. 2003 Feb 4;138(3):187-90. Erratum in: Ann Intern Med. 2003 Oct 7;139(7):605. PMID: 12558357 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Treatment for hepatitis C virus infection among inmates.

[No authors listed]

Ann Intern Med. 2003 Feb 4;138(3):I-50. No abstract available. PMID: 12558381 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response?

Sterling RK, Hofmann CM, Luketic VA, Sanyal AJ, Contos MJ, Mills AS, Shiffman ML.

Am J Gastroenterol. 2004 May;99(5):866-72.PMID: 15128352 [PubMed - indexed for MEDLINE]Related articles

High dose daily interferon-alpha induction and secondary adjunction of ribavirin in treatment-naive patients with chronic hepatitis C. A multicentric, randomised, controlled trial.

Wartelle-Bladou C, Arpurt JP, Renou C, Pariente A, Pillon D, Nalet B, Picon M, Glibert A, Chousterman M, Grasset D, Morin T, Bernard P, Fischer D, Ramdani M, Lagier E, Rotily M; Viral Hepatitis Group of the ANGH.

Gastroenterol Clin Biol. 2006 Apr;30(4):525-32.PMID: 16733374 [PubMed - indexed for MEDLINE]Related articlesFree article

Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy.

Myers RP, Benhamou Y, Bochet M, Thibault V, Mehri D, Poynard T.

AIDS. 2004 Jan 2;18(1):75-9.PMID: 15090832 [PubMed - indexed for MEDLINE]Related articles

Chronic hepatitis C virus infection in renal transplant: treatment and outcome.

Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.

Clin Transplant. 2006 Nov-Dec;20(6):677-83.PMID: 17100715 [PubMed - indexed for MEDLINE]Related articles

Chronic hepatitis C. Genotypes and response to anti-viral therapy among Saudi patients.

Al-Traif I, Handoo FA, Al-Jumah A, Al-Nasser M.

Saudi Med J. 2004 Dec;25(12):1935-8.PMID: 15711670 [PubMed - indexed for MEDLINE]Related articles

Effect of interferon alfa and ribavirin treatment on hepatitis C virus RNA in serum and peripheral blood mononuclear cells in children with chronic hepatitis C.

Majda-Stanisławska E, Bednarek M, Jóźwiak B, Sidorkiewicz M, Piekarska A, Kuydowicz J.

Acta Gastroenterol Belg. 2006 Apr-Jun;69(2):187-90.PMID: 16929613 [PubMed - indexed for MEDLINE]Related articles

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C; AIDS Clinical Trials Group A5071 Study Team.

N Engl J Med. 2004 Jul 29;351(5):451-9.PMID: 15282352 [PubMed - indexed for MEDLINE]Related articlesFree article

Interferon alfacon-1 and ribavirin versus interferon alpha-2b and ribavirin in the treatment of chronic hepatitis C.

Sjogren MH, Sjogren R, Holtzmuller K, Winston B, Butterfield B, Drake S, Watts A, Howard R, Smith M.

Dig Dis Sci. 2005 Apr;50(4):727-32.PMID: 15844709 [PubMed - indexed for MEDLINE]Related articles

Interferon beta 1a versus interferon beta 1a plus ribavirin for the treatment of chronic hepatitis C in Chinese patients: a randomized, placebo-controlled trial.

Han Q, Liu Z, Kang W, Li H, Zhang L, Zhang N.

Dig Dis Sci. 2008 Aug;53(8):2238-45. Epub 2007 Dec 13.PMID: 18080763 [PubMed - indexed for MEDLINE]Related articles

Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.

Soriano V, Núñez M, Camino N, Maida I, Barreiro P, Romero M, Martin-Carbonero L, Garcia-Samaniego J, González-Lahoz J.

Antivir Ther. 2004 Aug;9(4):505-9.PMID: 15456081 [PubMed - indexed for MEDLINE]Related articles

Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.

Gallegos-Orozco JF, Fuentes AP, Olivera-Martinez MA, Gutiérrez-Reyes G, Cortina D, Oregel JA, Pérez-Pruna C, Sixtos MS, Cruz-Castellanos S, Soto-Ramírez LE, Rodríguez-Díaz R, Fuentes-Romero L, Gutiérrez-Ruiz MC, Kershenobich D.

Rev Invest Clin. 2003 Mar-Apr;55(2):138-42.PMID: 12827916 [PubMed - indexed for MEDLINE]Related articles

Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.

Chu CM, Sheen IS, Liaw YF.

Infection. 2004 Jun;32(3):153-6.PMID: 15188075 [PubMed - indexed for MEDLINE]Related articles

Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

Samuel D, Bizollon T, Feray C, Roche B, Ahmed SN, Lemonnier C, Cohard M, Reynes M, Chevallier M, Ducerf C, Baulieux J, Geffner M, Albrecht JK, Bismuth H, Trepo C.

Gastroenterology. 2003 Mar;124(3):642-50.PMID: 12612903 [PubMed - indexed for MEDLINE]Related articles

Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen.

Lunel F, Veillon P, Fouchard-Hubert I, Loustaud-Ratti V, Abergel A, Silvain C, Rifflet H, Blanchi A, Causse X, Bacq Y, Payan C; Fontevraud Study Group.

J Hepatol. 2003 Nov;39(5):826-33.PMID: 14568267 [PubMed - indexed for MEDLINE]Related articles

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.

Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-García J, Lazzarin A, Carosi G, Sasadeusz J, Katlama C, Montaner J, Sette H Jr, Passe S, De Pamphilis J, Duff F, Schrenk UM, Dieterich DT; APRICOT Study Group.

N Engl J Med. 2004 Jul 29;351(5):438-50.PMID: 15282351 [PubMed - indexed for MEDLINE]Related articlesFree article

Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.

Yu ML, Chuang WL, Dai CY, Lee LP, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Tsai SL, Kuo HT.

Transl Res. 2006 Sep;148(3):120-7.PMID: 16938649 [PubMed - indexed for MEDLINE]Related articles

Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study.

Benetti G, Borzio M, Ramella G, Bellati G, Fargion S, Colombo A, Croce G, Iamoletti C, Balzola F, Rizzetto M; GEL (Gruppo Epatologico Lombardo).

Intern Emerg Med. 2006;1(2):113-8.PMID: 17111783 [PubMed - indexed for MEDLINE]Related articles

Combination therapy with interferon-alpha(2b), ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin.

Thuluvath PJ, Pande H, Maygers J.

Dig Dis Sci. 2003 Mar;48(3):594-7.PMID: 12757175 [PubMed - indexed for MEDLINE]Related articles